Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial. [electronic resource]
Producer: 20080129Description: 740-9 p. digitalISSN:- 1094-5539
- Administration, Inhalation
- Adrenergic beta-Agonists -- administration & dosage
- Adult
- Aged
- Blood Glucose -- drug effects
- Blood Pressure -- drug effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Electrocardiography
- Female
- Follow-Up Studies
- Forced Expiratory Volume -- drug effects
- Heart Rate -- drug effects
- Humans
- Indans -- administration & dosage
- Male
- Middle Aged
- Nebulizers and Vaporizers
- Potassium -- blood
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Quinolones -- administration & dosage
- Severity of Illness Index
- Time Factors
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.